Unknown

Dataset Information

0

Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer.


ABSTRACT: Locally advanced rectal cancer (LARC) comprises heterogeneous tumours with predominant hypoxic components. The hypoxia-inducible metabolic shift causes microenvironmental acidification generated by carbonic anhydrase IX (CAIX) and facilitates metastatic progression, the dominant cause of failure in LARC.Using a commercially available immunoassay, circulating CAIX was assessed in prospectively archived serial serum samples collected during combined-modality neoadjuvant treatment of LARC patients and correlated to histologic tumour response and progression-free survival (PFS).Patients who from their individual baseline level displayed serum CAIX increase above a threshold of 224 pg/ml (with 96 % specificity and 39 % sensitivity) after completion of short-course neoadjuvant chemotherapy (NACT) prior to long-course chemoradiotherapy and definitive surgery had significantly better 5-year PFS (94 %) than patients with below-threshold post-NACT versus baseline alteration (PFS rate of 56 %; p < 0.01). This particular CAIX parameter, ?NACT, was significantly correlated with histologic ypT0-2 and ypN0 outcome (p < 0.01) and remained an independent PFS predictor in multivariate analysis wherein it was entered as continuous variable (p = 0.04).Our results indicate that low ?NACT, i.e., a weak increase in serum CAIX level following initial neoadjuvant treatment (in this case two cycles of the Nordic FLOX regimen), might be used as risk-adapted stratification to postoperative therapy or other modes of intensification of the combined-modality protocol in LARC.ClinicalTrials.gov NCT00278694.

SUBMITTER: Hektoen HH 

PROVIDER: S-EPMC4513373 | biostudies-literature | 2015 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer.

Hektoen Helga Helseth HH   Flatmark Kjersti K   Andersson Yvonne Y   Dueland Svein S   Redalen Kathrine Røe KR   Ree Anne Hansen AH  

BMC cancer 20150724


<h4>Background</h4>Locally advanced rectal cancer (LARC) comprises heterogeneous tumours with predominant hypoxic components. The hypoxia-inducible metabolic shift causes microenvironmental acidification generated by carbonic anhydrase IX (CAIX) and facilitates metastatic progression, the dominant cause of failure in LARC.<h4>Methods</h4>Using a commercially available immunoassay, circulating CAIX was assessed in prospectively archived serial serum samples collected during combined-modality neoa  ...[more]

Similar Datasets

| S-EPMC4749816 | biostudies-literature
| S-EPMC6272707 | biostudies-literature
| S-EPMC7051959 | biostudies-literature
| S-EPMC7432807 | biostudies-literature
2010-07-01 | GSE20981 | GEO
| S-EPMC3461155 | biostudies-literature
| S-EPMC6047028 | biostudies-literature
| S-EPMC8232395 | biostudies-literature
| S-EPMC3575511 | biostudies-literature
| S-EPMC10707797 | biostudies-literature